Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04016324 · ClinicalTrials.gov registry record · NA
InterStim Basic Evaluation Lead Post-Market Clinical Follow-up Study
A NA study, sponsored by MedtronicNeuro.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT04016324 is a NA study that has completed, run by MedtronicNeuro. The registered enrollment target is 110 participants.
The verdict
NCT04016324, a NA study, has completed, sponsored by MedtronicNeuro.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
Post-market clinical follow-up for continued assessment of safety and performance of the InterStim basic evaluation lead and foramen needle(s) used during a therapy evaluation.
Interventions
- DEVICE InterStim Basic Evaluation lead and foramen needle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2019-11-28 |
| Est. Completion | 2020-10-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04016324
The ClinicalTrials.gov registry entry for NCT04016324 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which InterStim Basic Evaluation lead and foramen needle is the first listed.
NCT04016324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04016324 about?
NCT04016324 is a clinical study titled "InterStim Basic Evaluation Lead Post-Market Clinical Follow-up Study". Post-market clinical follow-up for continued assessment of safety and performance of the InterStim basic evaluation lead and foramen needle(s) used during a therapy evaluation.
What is the current status of trial NCT04016324?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2019-11-28. Estimated completion is 2020-10-09.
What interventions are being tested in trial NCT04016324?
The interventions under investigation include: InterStim Basic Evaluation lead and foramen needle (DEVICE).
Who is sponsoring clinical trial NCT04016324?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.